Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REAL-WORLD OBSERVATIONAL STUDY OF ZAVICEFTA (REGISTERED) (CEFTAZIDIME-AVIBACTAM) TO CHARACTERIZE USE PATTERNS, EFFECTIVENESS AND SAFETY - EZTEAM STUDY

NCT03923426 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03923426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03923426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REAL-WORLD OBSERVATIONAL STUDY OF ZAVICEFTA (REGISTERED) (CEFTAZIDIME-AVIBACTAM) TO CHARACTERIZE USE PATTERNS, EFFECTIVENESS AND SAFETY - EZTEAM STUDY
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 27, 2018
Completion date
March 28, 2022
Enrollment
572 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

infection